InnovAge forecasts $1.05B-$1.085B revenue and $105M-$115M adjusted EBITDA for fiscal 2027 as it targets 5%-7.5% census growth (NASDAQ:INNV)

InnovAge (INNV) Q4 2026 earnings call recap: FY2027 guidance, PACE growth strategy, margins, and Medicaid/Medicare rate risks (V28).

Continue in Briflio to read, react, comment, and share.